Different positive predictive values of commercially available human immunodeficiency virus enzyme-linked immunosorbent assays [2]

Clinical and Vaccine Immunology

Volumn 13, Issue 2, 2006, Pages 302-303

  Clark, Jesse L ^a   Coates, Thomas J ^b   Lescano, Andres G ^c   Castillo, Rosa ^c   Meza, Rina ^c   Jones, Franca R ^d   Leon, Segundo ^e   Pajuelo, Jose ^e   Caceres, Carlos F ^e   Klausner, Jeffrey D ^f  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c California   (Peru)

^d NAVAL MEDICAL RESEARCH CENTER   (United States)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^f SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERMETHOD COMPARISON; LETTER; PERU; PREDICTION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; WESTERN BLOTTING;

AIDS SERODIAGNOSIS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPREVALENCE; HIV-1; HUMANS; PERU; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 33644906629     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.13.2.302-303.2006     Document Type: Letter

References (5)

1. Centers for Disease Control and Prevention. 2003. Human immunodeficiency virus type 1 (HIV-1) rapid antibody testing. Report of results for the performance evaluation survey conducted during July 2003. Centers for Disease Control and Prevention Model Performance Evaluation Program. Centers for Disease Control and Prevention, Atlanta, Ga.
2. Gurtler, L. 1996. Difficulties and strategies of HIV diagnosis. Lancet 348:176-179.
3. Holodiny, M., and M. P. Busch. 2003. Establishing the diagnosis of HIV infection, p. 3-20. In R. Dolin, H. Masur, and M. S. Saag (ed.), AIDS therapy. Elsevier Science, New York, N.Y.
4. Mylonakis, E., M. Paliou, M. Lally, T. P. Flanigan, and J. D. Rich. 2000. Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches. Am. J. Med. 109:568-576.
5. World Health Organization. 2004. HIV assays: operational characteristics (phase 1). Report 14. Simple/rapid tests. World Health Organization, Geneva, Switzerland.